Transoral Surgery and Deintensified Adjuvant Therapy: Another Step in Determining Its Role in the Management of Human Papillomavirus Oropharyngeal Cancer Few effective systemic therapies were ...
Much-anticipated trial results were presented on the third day of the annual meeting of the American Society of Clinical Oncology, held in Chicago. These included phase 3 results from the CheckMate ...
In the first ever disclosure for the subcutaneous formulation of Opdivo, the CheckMate -67T Phase 3 trial demonstrates activity in advanced or metastatic clear cell renal cell carcinoma Company plans ...
(RTTNews) - Halozyme Therapeutics, Inc. (HALO) Thursday said Bristol Myers Squibb (BMS) reported positive topline results from the Phase 3 CheckMate-67T trial evaluating subcutaneous Opdivo (nivolumab ...
The use of anti-PD-1 antibodies to break immunological self-tolerance has shown impressive and broad-ranging antitumour responses in patients with melanoma, kidney cancer, and non-small-cell lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback